|
시장보고서
상품코드
2084623
암 및 비암 진단용 모노클로널 항체 시장 : 항체 유형별, 사용 기술별, 용도별, 최종사용자별, 유통 채널별, 지역별Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type, By Usage Techniques, By Application, By End User, By Distribution Channel, By Geography |
||||||
암 및 비암 진단용 모노클로널 항체 시장은 2026년에 101억 2,930만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 182억 9,120만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.8%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 101억 2,930만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 8.80% | 2033년 시장 규모 예측 : | 182억 9,120만 달러 |
전 세계 암 및 비암 진단용 단일클론 항체 시장에는 단일클론 항체를 기반으로 한 다양한 진단 제품이 포함되어 있습니다. 이러한 항체 기반 진단법은 종양학, 감염증, 자가면역질환, 심혈관 질환 등 다양한 임상 적응증에 걸친 수많은 질환의 검출, 감별 및 관리에 활용되고 있습니다. 단일클론 항체는 높은 특이도와 민감도 덕분에 면역조직화학(IHC), 효소면역측정법(ELISA), 유세포분석법, 동반진단 등 여러 고처리량 기술에서 널리 활용되고 있습니다.
암 발병률의 증가, 동반 진단에 대한 수요 증가, 그리고 병리학 및 분자 진단 플랫폼의 발전이 시장 확대를 이끄는 주요 요인으로 작용하고 있습니다. 감염병 진단, 자가면역질환 관리 및 맞춤형 치료 선택에 있으며, 단일클론 항체의 적용 범위가 확대됨에 따라 앞으로도 그 도입이 지속적으로 촉진될 것이며, 병원, 진단 검사실 및 연구 기관에서 단일클론 항체가 진단 수단으로서 중요한 툴로서의 입지를 더욱 공고히 할 것입니다.
시장 역학
암 및 비암 진단용 단일클론 항체 세계 시장은 암, 자가면역 질환, 감염증 등 신속하고 효과적인 진단이 필요한 만성질환의 증가에 힘입어 성장하고 있습니다. 또한 정밀 의학의 적용 확대와 더불어, 맞춤형 의료에서 환자의 치료 방침을 수립하기 위한 동반 진단제에 대한 수요가 증가함에 따라 시장 확대가 가속화될 것으로 보입니다. 단일클론 항체는 ELISA, IHC, 유세포분석, 바이오마커 검사 등 다양한 진단법에서 널리 사용되고 있으며, 그 결과 사용량이 증가하면서 시장 성장을 주도하고 있습니다.
그러나 시장에는 비용이 많이 드는 개발 및 검증 과정 및 규제 당국의 엄격한 승인이 필요하다는 점 등 몇 가지 제약이 존재합니다. 그럼에도 불구하고 질병의 조기 발견에 대한 꾸준한 수요는 물론, 암 진단에 대한 지출 증가, 질병의 정밀진단을 위한 다중 바이오마커 검사의 활용 확대, 그리고 동반 검사의 보급 확대가 시장 진입 기업에게 유망한 비즈니스 기회를 가져다줄 것으로 예상됩니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략)를 바탕으로, 암 및 비암 진단용 단일클론 항체 관련 세계 시장의 주요 업체들을 분석하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 이 '암 및 비암 진단용 단일클론 항체' 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 암 및 비암 진단용 단일클론 항체에 관한 세계 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 암 및 비암 진단용 모노클로널 항체 시장 : 항체 유형별, 2021-2033년
제5장 세계의 암 및 비암 진단용 모노클로널 항체 시장 : 사용 기술별, 2021-2033년
제6장 세계의 암 및 비암 진단용 모노클로널 항체 시장 : 용도별, 2021-2033년
제7장 세계의 암 및 비암 진단용 모노클로널 항체 시장 : 최종사용자별, 2021-2033년
제8장 세계의 암 및 비암 진단용 모노클로널 항체 시장 : 유통 채널별, 2021-2033년
제9장 세계의 암 및 비암 진단용 모노클로널 항체 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
KSA 26.07.14Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market is estimated to be valued at USD 10,129.3 Mn in 2026 and is expected to reach USD 18,291.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 10,129.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.80% | 2033 Value Projection: | USD 18,291.2 Mn |
The global monoclonal antibodies for cancer and non-cancer diagnostics market includes a diverse range of diagnostic products that are based on monoclonal antibodies. These antibody-based diagnostics are used to detect, distinguish, and manage a variety of diseases across different clinical indications, including oncology, infectious diseases, autoimmune diseases, and cardiovascular diseases. Due to their high levels of specificity and sensitivity, monoclonal antibodies find widespread use in several high-throughput techniques such as immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and companion diagnostics.
An increasing incidence of cancer, rising requirement for companion diagnostics and advancements in pathology and molecular diagnostic platforms are the key factors pushing the market's expansion. The expansion of monoclonal antibody applications in infectious disease diagnostics, the management of autoimmune disease and personalized therapy selection will continue to fuel adoption and cement monoclonal antibodies' status as crucial tools in the diagnostic arsenal across hospitals, diagnostic labs, and research organizations.
Market Dynamics
The global monoclonal antibodies for cancer and non-cancer diagnostics market is driven by the increasing number of chronic diseases that need prompt and effective diagnosis, such as cancer, autoimmune disorders, and infectious diseases. Furthermore, the expanding application of precision medicine coupled with a rising demand for companion diagnostics to guide patient treatments for personalized medicines will aid market expansion. Monoclonal antibodies are widely adopted in various diagnostic methods like ELISA, IHC, flow cytometry, and biomarker testing, resulting in augmented use and thus driving the market growth.
However, a number of constraints are present in the market, such as cost-intensive development and validation processes, as well as the need for thorough regulatory approvals. Nevertheless, robust demand for an earlier detection of the disease coupled with increased spending on cancer diagnostics, a growth in the use of multiplex biomarker tests for the precise diagnostics of the disease, and the increased uptake of companion tests are expected to provide lucrative opportunities for the market participants.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global monoclonal antibodies for cancer and non-cancer diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, QIAGEN N.V., Merck KGaA, Abcam plc, and Sino Biological, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global monoclonal antibodies for cancer and non-cancer diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monoclonal antibodies for cancer and non-cancer diagnostics market
Market Segmentation
- Antibody Type Insights (Revenue, USD Mn, 2021 - 2033)
- Murine Antibodies
- Rabbit Antibodies
- Chimeric Antibodies
- Humanized Antibodies
- Fully Human Antibodies
- Recombinant Antibodies
- Others
- Usage Techniques Insights (Revenue, USD Mn, 2021 - 2033)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescent Immunoassay (CLIA)
- Western Blot (WB)
- Immunohistochemistry (IHC)
- Immunoprecipitation (IP)
- Immunofluorescence (IF)
- Lateral Flow Assay
- Others
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Cancer
- Obstetrics
- Dengue
- Chikungunya
- Helicobacter pylori
- Syphilis
- HIV (Human immunodeficiency virus)
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Clinical and Diagnostic Laboratories
- Hospitals
- Biopharmaceutical Companies
- Research Institutions
- Others
- Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Offline
- Online
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- QIAGEN N.V.
- Merck KGaA
- Abcam plc
- Sino Biological, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Usage Techniques
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Application
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By End User
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Distribution Channel
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Murine Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Rabbit Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Chimeric Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Humanized Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Fully Human Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Recombinant Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Usage Techniques, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Chemiluminescent Immunoassay (CLIA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Western Blot (WB)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunohistochemistry (IHC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunoprecipitation (IP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunofluorescence (IF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Lateral Flow Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Obstetrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Dengue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Chikungunya
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Helicobacter pylori
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Syphilis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- HIV (Human immunodeficiency virus)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Clinical and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abcam plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sino Biological, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
